Design, Synthesis, and Characterization of Brequinar Conjugates as Probes to Study DHODH Inhibition
- 12 September 2017
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 23 (56) , 13875-13878
Abstract
Brequinar, a potent dihydroorotate dehydrogenase (DHODH) inhibitor, has been evaluated in multiple clinical trials as a potential treatment for cancer. To further understand brequinar‐based DHODH inhibition and DHODH′s therapeutic relevance in cancer, we have developed novel brequinar‐based probes. We disclose a 16‐step convergent synthesis of the first brequinar‐PROTAC and a four‐step approach towards the first mitochondrial‐directed brequinar probe. A PROTAC and mitochondria‐directed probe of brequinar both possess cytotoxicity that is superior to brequinar in a colony formation assay.Keywords
Funding Information
- University of Michigan Developmental Research (P50 CA130810)
This publication has 23 references indexed in Scilit:
- Dihydroorotate dehydrogenase (DHODH) inhibitors affect ATP depletion, endogenous ROS and mediate S-phase arrest in breast cancer cellsBiochimie, 2017
- Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffoldsEuropean Journal of Medicinal Chemistry, 2017
- Fluorescence assay of dihydroorotate dehydrogenase that may become a cancer biomarkerScientific Reports, 2017
- Induced protein degradation: an emerging drug discovery paradigmNature Reviews Drug Discovery, 2016
- Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid LeukemiaCell, 2016
- Small‐Molecule PROTACS: New Approaches to Protein DegradationAngewandte Chemie International Edition, 2016
- Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosisOncogene, 2013
- On Dihydroorotate Dehydrogenases and Their Inhibitors and UsesJournal of Medicinal Chemistry, 2013
- Recent Developments in the Medicinal Chemistry and Therapeutic Potential of Dihydroorotate Dehydrogenase (DHODH) InhibitorsMini-Reviews in Medicinal Chemistry, 2011
- DUP 785 (NSC 368390): Schedule-dependency of growth-inhibitory and antipyrimidine effectsBiochemical Pharmacology, 1988